ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 148

Value of Ultrasonography Parotid Glands in Patients with Suspected Primary Sjögren’s Syndrome

Marina Oliver1, Lida Santiago2, Paula Gonzalez1, Diego Vila1, Sebastian fernandez Nacul1, Santiago Scarafia3, Marta Mamani4 and Anastasia Secco3, 1Rheumatology, Rivadavia Hospital, Buenos Aires, Argentina, 2hospital rivadavia, CABA, Argentina, 3Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 4Hospital Rivadavia, Capital Federal, Argentina

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Diagnostic Tests, Sjogren's syndrome and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose

Primary Sjogren’s syndrome (pSS) is an autoimmune disorder characterised by chronic lymphocytic infiltration of exocrine tissues. Currently new non-invasive techniques are being continuously introduced as a diagnosis tool. Ultrasonography (US) of salivary glands in these patients merits special interest as a rapid, inexpensive, non-radiating and widely accessible modality.

Methods

The aim of the study is to  assess the diagnostic value of ultrasonography (US) in those patients underwent minor salivary gland biopsy (MSGB) by suspected Primary Sjögren Syndrome (pSS).

All patients underwent bilateral parotid glands US and MSGB. The same expert blinded examiner performed the US. All patients were scanned using an MyLab 25 US scanner (Esaote Italy) with a 10-18 MHz linear-array transducer. The following parameters were assessed: homogeneity, hypoechoic areas, hyperechoic foci, Power Doppler (PD) and margins graded from 0 to 2 (0: well-defined, 1: ill-defined, 2: blurred) and gland size was measured. The gold standard was the MSGB.  According to the quantity and type of US variables, we determined the following cut-off values (at least unilateral parotid finding) A: presence or absence of heterogeneity on unilateral or bilateral parotid glands B: presence or absence of any variable (not more than one and excluding heterogeneity) on unilateral or bilateral parotid glands. C: presence or absence of three or more variables (any variable) on unilateral or bilateral parotid glands. 

Results

We included a total of forty-five biopsies (32 negative and 13 positive). 95.56% were female, the median symptoms length was 2 years (IQR 1-7), no differences were observed between both groups. According to A cut-off values had 30. 77 % sensitivity (S) (CI 17.28- 44.25), 78.13% specificity (Sp) (CI 66.05-90.20), 36.36 % positive predictive value (PPV) (22.31-50.42), 73.53% Negative Predictive Value( NPV) (CI 60.64-86.42), likelihood ratio (LR) + 1.41 (CI 0.49-4.0), and the area under the curve (AUC) 0.54 (CI 0.40-0.69). B findings showed 46.15% S (CI 41.59- 60.72), 68.75% Sp (CI 55.21-82.29), 37.50% PPV (CI 23.36-51.64), 75.86% NPV (CI 63.86-88.36%), LR + 1.48 (CI 0.68-3.22), AUC 0.57 (CI 0.41-0.74). We observed C findings with a 30.77% of Sensitivity (CI 17.28-44.25), 90.63% Specificity (CI 82.11-99.14), 57.14% PPV (CI 42.78- 71.60), 31% NVP  (CI 63.89-88.74), LR + 3.28 (CI 0.85-12.67), AUC 0.61(CI 0.47-0.77).Bilateral parotid US showed an AUC similar to B findings .

Conclusion

We considered that C findings are the best cut-off values because it demonstrated greater specificity and slightly better AUC. Nevertheless, in our study the US of parotid gland not prove to be an appropriate diagnostic tool to replace the MSGB.


Disclosure:

M. Oliver,
None;

L. Santiago,
None;

P. Gonzalez,
None;

D. Vila,
None;

S. fernandez Nacul,
None;

S. Scarafia,
None;

M. Mamani,
None;

A. Secco,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/value-of-ultrasonography-parotid-glands-in-patients-with-suspected-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology